for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Johnson & Johnson

JNJ.N

Latest Trade

156.10USD

Change

3.03(+1.98%)

Volume

2,522,726

Today's Range

153.15

 - 

156.68

52 Week Range

109.17

 - 

173.62

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
153.07
Open
153.98
Volume
2,522,726
3M AVG Volume
168.50
Today's High
156.68
Today's Low
153.15
52 Week High
173.62
52 Week Low
109.17
Shares Out (MIL)
2,628.68
Market Cap (MIL)
410,336.90
Forward P/E
16.42
Dividend (Yield %)
2.59

Next Event

Q1 2021 Johnson & Johnson Earnings Release

Latest Developments

More

U.S. Centers For Disease Control Director Walensky Says New Report Shows That Increases In Daily Death Rates Slowed Significantly Within 20 Days Of Mask Mandates In Place

J&J Anticipates Fulfilling 10 Million Doses Included In Advance Purchase Agreement With The Government Of Canada By The End Of Q3 2021

Shine Justice Says Ethicon, Johnson & Johnson Mesh Appeal Dismissed

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Industry

Biotechnology & Drugs

Contact Info

1 Johnson And Johnson Plz

NEW BRUNSWICK, NJ

08933-0001

United States

+1.732.5242455

https://www.jnj.com/

Executive Leadership

Alex Gorsky

Chairman of the Board, Chief Executive Officer

Paulus A. Stoffels

Vice Chairman- Executive Committee, Chief Scientific Officer

Joaquin Boix Duato

Vice Chairman - Executive Committee

Joseph J. Wolk

Chief Financial Officer, Executive Vice President

Peter M. Fasolo

Chief Human Resource Officer, Executive Vice President

Key Stats

2.00 mean rating - 19 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

81.6K

2019

82.1K

2020

82.6K

2021(E)

91.9K
EPS (USD)

2018

8.180

2019

8.680

2020

8.030

2021(E)

9.496
Price To Earnings (TTM)
28.91
Price To Sales (TTM)
4.97
Price To Book (MRQ)
6.49
Price To Cash Flow (TTM)
18.96
Total Debt To Equity (MRQ)
55.73
LT Debt To Equity (MRQ)
51.57
Return on Investment (TTM)
11.34
Return on Equity (TTM)
8.67

Latest News

Latest News

Canada approves J&J's COVID-19 vaccine, moves up some Pfizer deliveries

Canada's drug regulator on Friday approved Johnson & Johnson's COVID-19 vaccine, the fourth such shot to be given the green light, as Ottawa brought forward deliveries of millions of Pfizer doses.

BRIEF-Health Canada Approves Johnson & Johnson's Covid-19 Vaccine - Government Source

Health Canada approves Johnson & Johnson's COVID-19 vaccine - government source Further company coverage: (Reporting by Steve Scherer)

Canada to authorize Johnson & Johnson's COVID-19 vaccine: CBC News

Health Canada will announce the approval of Johnson & Johnson's single-dose COVID-19 vaccine on Friday, CBC News reported, citing sources.

Canada approves Johnson & Johnson's one-dose COVID-19 vaccine - CBC

Canada's drug regulator has approved Johnson & Johnson's single-dose COVID-19 vaccine, the Canadian Broadcasting Corp. said on Friday, citing an unidentified source.

UPDATE 1-Denmark pushes back date for all citizens to be vaccinated to July

Denmark has pushed back the final date for when it expects all Danes to have been fully vaccinated against COVID-19 to July 18 after shipments from Johnson & Johnson and Curevac were delayed, local media reported on Friday, citing ministry documents.

J&J loses appeal in Australian pelvic mesh class action

An Australian court on Friday dismissed an appeal by Johnson & Johnson against a ruling that its subsidiary Ethicon had misled patients and surgeons about the risks of its pelvic mesh implants.

J&J to SCOTUS: Plaintiffs’ lawyers’ ‘winning formula’ for $2.1 bln talc award violates due process

Johnson & Johnson has asked the U.S. Supreme Court to hear its appeal of a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in its baby powder and other talc products.

U.S. will invest $100 million to help J&J and Merck vaccine partnership

The White House said the federal government in planning to spend $100 million to help the recently announced vaccine partnership between Merck & Co and rival Johnson & Johnson, White House senior adviser Andy Slavitt said on Wednesday.

American Airlines to launch first employee vaccine site at Chicago's O'Hare

American Airlines will on Thursday begin providing employees with a limited supply of Johnson & Johnson's single-shot COVID-19 vaccine at Chicago's O'Hare airport, according to a letter sent to Chicago-based employees.

Biden calls on states to prioritize vaccinations for teachers

President Joe Biden on Tuesday called on U.S. states to prioritize COVID-19 vaccinations for teachers to ensure children could return to school quickly and safely, and said every educator should receive at least one shot by the end of March.

Biden says will have enough COVID-19 vaccine for every U.S. adult by May

The United States will have enough COVID-19 vaccine for every American adult by the end of May, President Joe Biden said on Tuesday after Merck & Co agreed to make rival Johnson & Johnson's inoculation.

White House using Defense Production Act to equip Merck plants for Johnson & Johnson vaccine

The United States is using the Defense Production Act to equip drugmaker Merck & Co's plants to make Johnson & Johnson's just approved COVID-19 vaccine, White House press secretary Jen Psaki said on Tuesday.

Merck to help make Johnson & Johnson's vaccine - Washington Post

Merck & Co Inc will help make rival Johnson & Johnson's single-shot COVID-19 vaccine, the Washington Post reported on Tuesday, citing senior officials from U.S. President Joe Biden's administration.

BRIEF-Merck Will Help Make Johnson & Johnson Coronavirus Vaccine - Washington Post

* MERCK WILL HELP MAKE JOHNSON & JOHNSON CORONAVIRUS VACCINE - WASHINGTON POST

J&J waiting on new plant approval to ship high volumes of vaccine: executive

Johnson & Johnson is waiting on regulatory approval of a new, larger plant operated by contract manufacturer Catalent Inc to begin large-scale U.S. deliveries of its just-authorized COVID-19 vaccine following initial shipments this week, a top J&J executive said on Monday.

J&J COVID-19 vaccine shipping to U.S., but new deliveries hinge on regulators

Johnson & Johnson will ship nearly 4 million doses of its newly authorized single-dose COVID-19 vaccine around the United States this week, but a top executive said on Monday that the next round of deliveries is contingent on regulatory approvals at a new plant.

Chile to ramp up purchase of Sinovac vaccine, seeking deal with Johnson & Johnson

Chile plans to ramp up its purchase of vaccines from China's Sinovac and hopes to sign a deal shortly with Johnson & Johnson, the health minister said on Monday, as the South American nation moves to strengthen its widely lauded coronavirus vaccination campaign.

Chile to ramp up purchase of Sinovac vaccine, seeking deal with Johnson & Johnson

Chile plans to ramp up its purchase of vaccines from China's Sinovac and hopes to ink a deal shortly with Johnson & Johnson, the health minister said on Monday, as the South American nation moves to strengthen its widely lauded coronavirus vaccination campaign.

CORRECTED-US STOCKS-Wall St jumps on J&J vaccine cheer, stimulus optimism

Wall Street's major averages rose 1.5% on Monday as bond markets calmed after a month-long selloff, while encouraging updates on the vaccine and stimulus fronts strengthened bets over a swift economic recovery.

US STOCKS SNAPSHOT-Wall St opens higher on J&J vaccine cheer, stimulus optimism

Wall Street's major averages opened higher on Monday as bond markets calmed after a month-long selloff, while encouraging updates on the vaccine and stimulus fronts strengthened bets over a swift economic recovery.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up